Chapter
Licensed
Unlicensed
Requires Authentication
Management of the premenstrual syndrome
-
A. L. Magos
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter I
- Contents V
- Opening remarks 1
- Prologue 3
-
1. Physiology and pathophysiology of the perimenopausal years
- Some aspects of oogenesis, follicular growth, and endocrine involution 11
- The climacteric syndrome 39
- Skin and the menopause 57
- Osteoporosis: occurrence and diagnosis 69
- Lipids, hormonal status and the cardiovascular system in the postmenopause 77
- Psychosocial aspects in the perimenopause 87
- The bladder in the menopausal woman 93
- Discussion 103
-
2. Management of the climacteric patient
-
2.1. General aspects
- The influence of nutrition and exercise 109
- Non-hormonal medication 117
- Discussion 126
-
2.2. Hormonal treatment
- Selection of patients — kind and duration of treatment 129
- Routes of estrogen administration 141
- Sex steroids and lipoproteins 149
- Discussion 153
-
2.3. Risk-benefit evaluation of hormonal therapy
- Prospective study on long term risk of hormone replacement therapy 157
- Long-term metabolic effects of estrogen therapy 163
- Hormonal replacement therapy and breast cancer 177
- Prevention of endometrial abnormalities 189
- Estrogen/progestogen as a prophylactic treatment of postmenopausal osteoporosis 207
- Discussion 213
-
2.4. Special aspects in premenopausal women
- Management of the premenstrual syndrome 221
- Contraception in premenopausal age 233
- Discussion 249
- Closing remarks 251
- Epilogue 253
- List of contributors 255
- Backmatter 257
Chapters in this book
- Frontmatter I
- Contents V
- Opening remarks 1
- Prologue 3
-
1. Physiology and pathophysiology of the perimenopausal years
- Some aspects of oogenesis, follicular growth, and endocrine involution 11
- The climacteric syndrome 39
- Skin and the menopause 57
- Osteoporosis: occurrence and diagnosis 69
- Lipids, hormonal status and the cardiovascular system in the postmenopause 77
- Psychosocial aspects in the perimenopause 87
- The bladder in the menopausal woman 93
- Discussion 103
-
2. Management of the climacteric patient
-
2.1. General aspects
- The influence of nutrition and exercise 109
- Non-hormonal medication 117
- Discussion 126
-
2.2. Hormonal treatment
- Selection of patients — kind and duration of treatment 129
- Routes of estrogen administration 141
- Sex steroids and lipoproteins 149
- Discussion 153
-
2.3. Risk-benefit evaluation of hormonal therapy
- Prospective study on long term risk of hormone replacement therapy 157
- Long-term metabolic effects of estrogen therapy 163
- Hormonal replacement therapy and breast cancer 177
- Prevention of endometrial abnormalities 189
- Estrogen/progestogen as a prophylactic treatment of postmenopausal osteoporosis 207
- Discussion 213
-
2.4. Special aspects in premenopausal women
- Management of the premenstrual syndrome 221
- Contraception in premenopausal age 233
- Discussion 249
- Closing remarks 251
- Epilogue 253
- List of contributors 255
- Backmatter 257